Medical News

RSS

SynCare receives NCQA Accreditation for high-risk pregnancy program

SynCare, LLC has received National Committee for Quality Assurance Patient and Practitioner Oriented Full Accreditation for its high-risk pregnancy program, the SynCare Promise Program™ for Prenatal Care.

26 Feb 2010

BPA exposure during pregnancy may cause permanent reproduction problems for female offspring

Here's more evidence that "safe" plastics are not as safe as once presumed: New research published online in The FASEB Journal suggests that exposure to Bisphenol A (BPA) during pregnancy leads to epigenetic changes that may cause permanent reproduction problems for female offspring. BPA, a common component of plastics used to contain food, is a type of estrogen that is ubiquitous in the environment.

26 Feb 2010

Manhattan Scientifics completes agreement to acquire all commercial rights to Senior Scientific

Manhattan Scientifics Inc., a nanomedicine technology transfer and commercialization pioneer, today announced completion of its agreement to acquire all commercial rights to the body of work of nuclear physicist Edward R. Flynn, PhD and his company, Senior Scientific LLC.

26 Feb 2010

Accelerated radiation therapy helps reduce amount of chemotherapy in advanced head and neck cancer patients

Using an accelerated, shorter course of radiation therapy for patients with advanced head and neck cancer allows doctors to reduce the amount of chemotherapy, thus reducing toxicity, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

26 Feb 2010

Misperceptions about risk, symptoms and lethality of lung cancer increase mortality rates for lung cancer

A new analysis published this week in the journal Cancer indicates that misperceptions about risk, symptoms and the lethality of lung cancer may play a role in the disproportionately higher incidence and mortality rates for lung cancer among African Americans.

26 Feb 2010

Study confirms efficacy and tolerability of lacosamide for uncontrolled POS

A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients.

26 Feb 2010

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on HAE

Hereditary angioedema (HAE) can be difficult to accurately diagnose and equally difficult to effectively treat. To overcome the many obstacles to managing the care of patients with HAE, healthcare professionals must be aware of the most up-to-date clinical data regarding HAE diagnosis and treatment.

26 Feb 2010

Medicare fraud: Brookhaven Memorial Hospital Medical Center agrees to pay $2.92M for resolving allegations

Brookhaven Memorial Hospital Medical Center, a Long Island, N.Y.-based hospital, has agreed to pay $2.92 million, plus interest, to settle allegations that the hospital defrauded Medicare, the Justice Department announced today.

26 Feb 2010

House passes bill to repeal antitrust exemption for health insurers

he House passed legislation Wednesday (406-19) to strip health insurers of their federal antitrust exemption.

26 Feb 2010

Resverlogix commences enrollment in RVX-208 Phase 2 clinical trial for atherosclerosis in ACS patients

Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.

26 Feb 2010

Genta initiates new dose-ranging study of tesetaxel drug

Genta Incorporated announced that the Company has initiated a new dose-ranging study of tesetaxel, the Company’s novel oral tubulin inhibitor, using a weekly dosing regimen. Tesetaxel -- a late Phase 2 oncology product -- is the leading oral taxane currently in clinical development.

26 Feb 2010

USPTO issues notice of allowance for Vanda Pharmaceuticals' Fanapt long-acting injectable formulation

Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanapt™ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.

26 Feb 2010

Ferring Pharmaceuticals, GSN sign agreement to test Parental Support technology

Ferring Pharmaceuticals and Gene Security Network announced that they have signed an agreement to conduct a clinical trial of GSN's advanced preimplantation genetic diagnosis (PGD) technology, Parental Support™.

26 Feb 2010

Mathematics of sleep-wake cycle

Why can't I fall asleep? Will this new medication keep me up all night? Can I sleep off this cold? Despite decades of research, answers to these basic questions about one of our most essential bodily functions remain exceptionally difficult to answer. In fact, researchers still don't fully understand why we even sleep at all. In an effort to better understand the sleep-wake cycle and how it can go awry, researchers at Rensselaer Polytechnic Institute are taking a different approach than the traditional brain scans and sleep studies. They are using mathematics.

26 Feb 2010

Scientists identify new way to treat castrate resistant cells in prostate cancer patients

Monash University biomedical scientists have identified a new way to treat castrate resistant cells in prostate cancer sufferers - the most common cancer in Australian men.

25 Feb 2010

New fatigue rating scale predicts increased risk of heart attack in dialysis patients

For dialysis patients, high scores on a new fatigue rating scale predict an increased risk of heart attack or other cardiovascular events, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

25 Feb 2010

Connecticut has especially high insurance hikes, disability advocates worry about Medicaid cuts in Tennessee

The Hartford Courant: "With average rate hikes at 13 percent or more this year for most plans, Connecticut health insurance premiums appear to be rising faster than the nation's. A typical family plan in Connecticut sold through an employer costs about $14,500 -- an estimate based on the Kaiser Family Foundation's report on 2009 prices and this year's rates of growth.

25 Feb 2010

New research using MRI shows that childhood stress can lead to structural brain changes

New research using magnetic resonance imaging (MRI) shows that childhood stress such as abuse or emotional neglect, in particular when combined with genetic factors, can result in structural brain changes, rendering these people more vulnerable to developing depression. The study led by scientists at Trinity College Dublin has just been published in the international scientific journal, Neuropsychopharmacology.

25 Feb 2010

TMI's Glider balloon catheter for PTA of lesions in peripheral vasculature receives FDA marketing clearance

TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for its newest product, the Glider™ balloon catheter, for percutaneous transluminal angioplasty (PTA) of lesions in the peripheral vasculature including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries.

25 Feb 2010

Bipartisanship unlikely after health summit; Party unity Obama's next best bet

Democratic and Republican lawmakers each have an opportunity to make bipartisan concessions during Thursday's summit - like warming to malpractice reform or publicly conceding Democratic plans would ultimately lower the deficit, respectively - but political pressure will likely push both sides towards their partisan ranks, Politico reports.

25 Feb 2010

Medical News

SynCare receives NCQA Accreditation for high-risk pregnancy program

BPA exposure during pregnancy may cause permanent reproduction problems for female offspring

Manhattan Scientifics completes agreement to acquire all commercial rights to Senior Scientific

Accelerated radiation therapy helps reduce amount of chemotherapy in advanced head and neck cancer patients

Misperceptions about risk, symptoms and lethality of lung cancer increase mortality rates for lung cancer

Study confirms efficacy and tolerability of lacosamide for uncontrolled POS

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on HAE

Medicare fraud: Brookhaven Memorial Hospital Medical Center agrees to pay $2.92M for resolving allegations

House passes bill to repeal antitrust exemption for health insurers

Resverlogix commences enrollment in RVX-208 Phase 2 clinical trial for atherosclerosis in ACS patients

Genta initiates new dose-ranging study of tesetaxel drug

USPTO issues notice of allowance for Vanda Pharmaceuticals' Fanapt long-acting injectable formulation

Ferring Pharmaceuticals, GSN sign agreement to test Parental Support technology

Mathematics of sleep-wake cycle

Scientists identify new way to treat castrate resistant cells in prostate cancer patients

New fatigue rating scale predicts increased risk of heart attack in dialysis patients

Connecticut has especially high insurance hikes, disability advocates worry about Medicaid cuts in Tennessee

New research using MRI shows that childhood stress can lead to structural brain changes

TMI's Glider balloon catheter for PTA of lesions in peripheral vasculature receives FDA marketing clearance

Bipartisanship unlikely after health summit; Party unity Obama's next best bet

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News